Charles Explorer logo
🇬🇧

The EUCLID Study (Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease)

Publication at First Faculty of Medicine |
2018

Abstract

In patients with symptomatic peripheral artery disease, ticagrelor was not shown to be superior to clopidogrel in the reductionof cardiovascular events during a 30-month follow-up period; the only significant difference between the groups was in the rateof ischemic stroke. The rates of major bleeding were similar among the patients in the two trial groups.